Altus Research | Women's Health Studies

Research site

(Unclaimed)

Location

4761 South Congress Avenue, Suite 100-B, Lake Worth, Florida, United States of America

Site insights

Top conditions

Top treatments

Estradiol

Elagolix

Fluconazole

Mesafem

Bimagrumab

fezolinetant

VT-1161

Norethindrone Acetate

SCY-078

Tirzepatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 72 total trials

A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight (RESTRAIN-SUI)

The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron work...

Not yet enrolling

Urinary Incontinence,Stress

Drug: Placebo

Drug: Orforglipron

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

The main purpose of this study is to evaluate the efficacy and safety of Bimagrumab and Tirzepatide, alone or in combination, in adults with obesity...

Active, not recruiting

Overweight

Obesity

Drug: Tirzepatide Placebo

Drug: Bimagrumab

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling

Obesity

Drug: Placebo

Drug: Naltrexone-Bupropion (NB) Combination

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The seco...

Active, not recruiting

Contraception

Change in Bone Mineral Density

Drug: Drospirenone

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting

Women at Risk for Pregnancy

Drug: VeraCept

FemBloc® Permanent Contraception - Early Pivotal Trial (BLOC)

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterili...

Active, not recruiting

Contraception

Device: FemBloc

Procedure: Laparoscopic bilateral tubal sterilization

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Enrolling

Female Contraception

Drug: Transdermal system containing progestin